INTERGRATED DIA.H DL 025
Research INTERGRATED DIA.H DL 025 (8I8) on Bullrun: market cap EUR 287.10M, P/E 11.3, dividend yield 1.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker8I8
- ExchangeF
- CountryJersey
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyEUR
- Market capEUR 287.10M
- P/E11.3
- Dividend yield1.6%
- Financial periodFY2025
- RevenueEUR 7.86B
- Revenue growth37.3%
- Net incomeEUR 1.26B
- Free cash flowEUR 1.38B
- Gross margin42.7%
Valuation Snapshot
latest market cap is EUR 287.10M; P/E is 11.3; dividend yield is 1.6%.
About INTERGRATED DIA.H DL 025
Integrated Diagnostics Holdings plc, a consumer healthcare company, provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics.
Frequently asked questions
What is INTERGRATED DIA.H DL 025's market cap?
INTERGRATED DIA.H DL 025's market capitalization is EUR 287.10M.
What is INTERGRATED DIA.H DL 025's P/E ratio?
INTERGRATED DIA.H DL 025's price-to-earnings (P/E) ratio is 11.3.
Does INTERGRATED DIA.H DL 025 pay a dividend?
INTERGRATED DIA.H DL 025 has a dividend yield of 1.6%.
What does INTERGRATED DIA.H DL 025 do?
Integrated Diagnostics Holdings plc, a consumer healthcare company, provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology,...